GSK3B and hepatocellular carcinoma: Furthermore, the CXCL16→CXCR6 axis reduces p38 MAPK activity in hepatocellular carcinoma SK-HEP-1 and HCCLM3 cells, which leads to the activation of GSK3β and consequently, to a decreased amount of β-catenin in the plasma membrane [48].